• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物洗脱球囊血管成形术治疗颈动脉支架内再狭窄。

Drug-eluting balloon angioplasty for carotid in-stent restenosis.

机构信息

Cardiovascular and Neurological Department, San Donato Hospital, Arezzo, Italy.

出版信息

J Endovasc Ther. 2012 Dec;19(6):729-33. doi: 10.1583/JEVT-12-3942R.1.

DOI:10.1583/JEVT-12-3942R.1
PMID:23210869
Abstract

PURPOSE

To report midterm results of 3 cases in which drug-eluting balloons (DEBs) were successfully used for the management of carotid in-stent restenosis (ISR).

CASE REPORT

Two women aged 68 and 70 years and a 68-year-old man were referred to our institution for asymptomatic severe stenosis [>80% with peak systolic velocity (PSV) >300 cm/s by Doppler ultrasound assessment] of individual Carotid Wallstents implanted in the proximal left internal carotid artery (ICA). In the angiosuite, the left ICA was engaged in a telescopic fashion with a triple coaxial system formed by a 6-F long sheath and a preloaded 5-F, 125-cm diagnostic catheter over a 0.035-inch soft hydrophilic guidewire. Under distal filter protection, the lesions were predilated using a 3.5 × 20-mm coronary balloon and then treated with two 1-minute inflations of a 4 × 40-mm Amphirion In.Pact paclitaxel-eluting balloon, followed by 3 months of dual antiplatelet therapy. At 12, 22, and 36 months, respectively, the patients are still asymptomatic, with duplex-documented stent patency at 6, 12, and 24 months, respectively.

CONCLUSION

DEBs are an emerging strategy for carotid ISR, with encouraging midterm results in these patients. Further experience in larger cohorts is needed to confirm these preliminary observations.

摘要

目的

报告 3 例使用药物洗脱球囊(DEB)成功治疗颈动脉支架内再狭窄(ISR)的中期结果。

病例报告

2 名女性患者年龄分别为 68 岁和 70 岁,1 名 68 岁男性,因无症状性严重狭窄[多普勒超声评估的狭窄率>80%,收缩期峰值流速(PSV)>300cm/s]就诊于我院,分别于左侧颈内动脉近端植入颈动脉 Wallstent。在血管造影套件中,通过 6-F 长鞘和预装 5-F、125-cm 诊断导管套叠在 0.035 英寸软亲水导丝上的三同轴系统,进行左颈内动脉(ICA)的血管内操作。在远端滤器保护下,使用 3.5×20mm 冠状动脉球囊对病变进行预扩张,然后使用 2 个 4×40mm Amphirion In.Pact 紫杉醇洗脱球囊进行 1 分钟的扩张,之后进行 3 个月的双联抗血小板治疗。分别在 12、22 和 36 个月时,患者仍然无症状,双功能超声检查分别在 6、12 和 24 个月时显示支架通畅。

结论

DEB 是颈动脉 ISR 的一种新兴治疗策略,这些患者的中期结果令人鼓舞。需要更大的队列经验来证实这些初步观察结果。

相似文献

1
Drug-eluting balloon angioplasty for carotid in-stent restenosis.药物洗脱球囊血管成形术治疗颈动脉支架内再狭窄。
J Endovasc Ther. 2012 Dec;19(6):729-33. doi: 10.1583/JEVT-12-3942R.1.
2
Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report.药物洗脱球囊治疗颈动脉支架置入术后支架内再狭窄:初步报告。
J Endovasc Ther. 2012 Dec;19(6):734-42. doi: 10.1583/JEVT-12-4042R.1.
3
Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.药物洗脱球囊血管成形术治疗难治性复发性颈动脉支架内再狭窄的长期结果
J Endovasc Ther. 2014 Oct;21(5):671-7. doi: 10.1583/14-4715MR.1.
4
Drug-coated balloon dilation before carotid artery stenting of post-carotid endarterectomy restenosis.颈动脉内膜剥脱术后再狭窄患者在颈动脉支架置入术前进行药物涂层球囊扩张。
J Endovasc Ther. 2015 Apr;22(2):212-6. doi: 10.1177/1526602815573498.
5
Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results.药物洗脱与标准球囊血管成形术治疗髂动脉支架再狭窄:中期结果
J Endovasc Ther. 2015 Jun;22(3):314-8. doi: 10.1177/1526602815583851.
6
Management of in-sent restenosis after carotid artery stenting in high-risk patients.高危患者颈动脉支架置入术后支架内再狭窄的管理。
J Vasc Surg. 2006 Feb;43(2):305-12. doi: 10.1016/j.jvs.2005.10.040.
7
Zotarolimus-eluting stent for the treatment of recurrent, severe carotid artery in-stent stenosis in the TARGET-CAS population.西罗莫司药物洗脱支架治疗 TARGET-CAS 人群中复发性、严重颈动脉支架内再狭窄
J Endovasc Ther. 2012 Jun;19(3):316-24. doi: 10.1583/11-3805R.1.
8
Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.药物涂层球囊治疗股浅动脉支架内再狭窄:2 年随访。
JACC Cardiovasc Interv. 2014 Apr;7(4):411-5. doi: 10.1016/j.jcin.2013.11.020. Epub 2014 Mar 14.
9
Commentary: drug-eluting balloons for carotid in-stent restenosis: can this technology deliver the goods?评论:用于颈动脉支架置入术后再狭窄的药物洗脱球囊:这项技术能带来预期效果吗?
J Endovasc Ther. 2012 Dec;19(6):743-8. doi: 10.1583/JEVT-12-3942C.1.
10
Optimal carotid duplex velocity criteria for defining the severity of carotid in-stent restenosis.用于定义颈动脉支架内再狭窄严重程度的最佳颈动脉双功超声速度标准。
J Vasc Surg. 2008 Sep;48(3):589-94. doi: 10.1016/j.jvs.2008.04.004. Epub 2008 Jun 30.

引用本文的文献

1
Recurrent carotid artery stenosis successfully and safely treated with drug-coated balloon angioplasty under flow reversal.在血流逆转情况下,药物涂层球囊血管成形术成功且安全地治疗复发性颈动脉狭窄。
J Vasc Surg Cases Innov Tech. 2025 Jan 15;11(2):101728. doi: 10.1016/j.jvscit.2025.101728. eCollection 2025 Apr.
2
Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and Indications.神经血管领域中的药物涂层球囊:当前应用与适应症的全面系统综述
Rev Cardiovasc Med. 2022 Apr 2;23(4):128. doi: 10.31083/j.rcm2304128. eCollection 2022 Apr.
3
Drug-Coated Balloons for Treatment of Internal Carotid Artery Restenosis After Stenting: A Single-Center Mid-Term Outcome Study.
药物涂层球囊治疗支架内颈内动脉再狭窄:单中心中期结果研究。
Cardiovasc Intervent Radiol. 2024 Mar;47(3):291-298. doi: 10.1007/s00270-024-03663-7. Epub 2024 Feb 7.
4
Treatment of the Carotid In-stent Restenosis: A Systematic Review.颈动脉支架置入术后再狭窄的治疗:一项系统评价。
Front Neurol. 2021 Oct 4;12:748304. doi: 10.3389/fneur.2021.748304. eCollection 2021.
5
Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report.冠状动脉生物可吸收血管支架成功治疗复发性颈动脉支架内再狭窄及药物洗脱球囊治疗失败:一例报告
Int J Surg Case Rep. 2016;21:78-82. doi: 10.1016/j.ijscr.2016.02.035. Epub 2016 Feb 27.